NALOXONE HYDROCHLORIDE
- Product NDC
- 51662-1544
- 11-digit product format
- 516621544
- Labeler code
- 51662
- Product ID
- 51662-1544_10352ea7-15c5-5c6c-e063-6394a90ae130
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- NALOXONE HYDROCHLORIDE
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Application
- ANDA212455
- Marketing category
- ANDA
- Marketing start
- 2021-08-08
- Substance
- NALOXONE HYDROCHLORIDE
- Active strength
- .4 mg/mL
- Pharmacologic classes
- Opioid Antagonist [EPC], Opioid Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| F850569PQR | NALOXONE HYDROCHLORIDE | 357-08-4 | NALOXONE HYDROCHLORIDE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 51662-1544-1 | 51662154401 | 1 mL in 1 VIAL, SINGLE-DOSE (51662-1544-1) | 1 ml | 2021-08-08 | No | No | Historical |
| 51662-1544-3 | 51662154403 | 10 POUCH in 1 CASE (51662-1544-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1544-2) / 1 mL in 1 VIAL, SINGLE-DOSE | 10 pouch | 2022-04-22 | No | No | Historical |